KD of iRhom1 via the NPs led to a significant improvement in tumor immune microenvironment as evident from increases in both the total numbers of CD8+ T cells and the numbers of functional (IFNγ+ or GzmB+) CD8+ T cells. The gene discussed is IFNG; the disease is neoplasm.